Recent COVID-19 News Updates
The antiparasitic drug ivermectin has not been approved by the Food and Drug Administration for the prevention or treatment of COVID-19.
In mid-August, the U.S. Food and Drug Administration approved the use of a third dose of the Pfizer and Moderna COVID-19 vaccines for immunocompromised people.
Obstetricians Julie A. Braga, MD, and Ilana Cass, MD, recently held a virtual event to share information about the safety and efficacy of the vaccines.
Data proves that all three currently approved vaccines are both effective and safe.
Every year, the common cold and the flu circulate in our communities, primarily in the fall and winter months, and make many people sick.
A panel of Dartmouth-Hitchcock experts recently addressed the topic during a virtual question-and-answer event.
Dartmouth-Hitchcock Health Promotes COVID-19 Vaccination Confidence with New Community Webinar Series
Project ECHO series to begin on Thursday, September 30
Struggling to Follow Ever-Changing COVID-19 Information? Dartmouth-Hitchcock Doctor to give Pandemic Update in Upcoming Webinar
Michael S. Calderwood, MD, MPH, to discuss virus variants, vaccines.
D-HH Launches Third Installment of its Virtual Roundtable Series as Effects of COVID-19 Pandemic Continue
“Heads Up: Coping Through COVID-19” is a pre-recorded series of virtual conversations featuring D-HH mental health experts, community partners and other experts offering information and tips for people of all ages
National staffing crisis, pandemic resurgence have increased local impacts; health providers ask for understanding and patience as they make the best, difficult decisions to ensure excellent care